HR 863 · 116th Congress 2019–2021, ended

DXM Abuse Prevention Act of 2019

Latest action · Jan 30, 2019 Referred to the House Committee on Energy and Commerce.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 30, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

DXM Abuse Prevention Act of 2019

This bill addresses the sale and distribution of dextromethorphan (DXM).

Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer.

The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.

Cosponsors 3

Members who signed on, in the order they did. Signatures ran from Jan 30, 2019 to Feb 7, 2019; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-OHBill JohnsonOriginalJan 30, 2019
D-NYYvette D. ClarkeFeb 6, 2019
D-WIRon KindFeb 7, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jan 30, 2019

Actions 2

Everything that happened, newest first.

  1. Jan 30, 2019Introduced in House
  2. Jan 30, 2019Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8, clause, which 3 provides Congress with the power to ``regulate commerce with foreign nations, and among the several states, and with the Indian tribes.''

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 19, January 30, 2019, page H1337.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 116-510MILITARY SPACE OPERATIONS, POLICY, AND PROGRAMS105 pagesArmed Services CommitteeMar 27, 2019

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes.
Short Title(s) as Introduced
DXM Abuse Prevention Act of 2019

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jan 30, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.